Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220789904> ?p ?o ?g. }
- W4220789904 endingPage "e055596" @default.
- W4220789904 startingPage "e055596" @default.
- W4220789904 abstract "Ebola virus disease (EVD) continues to be a significant public health problem in sub-Saharan Africa, especially in the Democratic Republic of the Congo (DRC). Large-scale vaccination during outbreaks may reduce virus transmission. We established a large population-based clinical trial of a heterologous, two-dose prophylactic vaccine during an outbreak in eastern DRC to determine vaccine effectiveness.This open-label, non-randomised, population-based trial enrolled eligible adults and children aged 1 year and above. Participants were offered the two-dose candidate EVD vaccine regimen VAC52150 (Ad26.ZEBOV, Modified Vaccinia Ankara (MVA)-BN-Filo), with the doses being given 56 days apart. After vaccination, serious adverse events (SAEs) were passively recorded until 1 month post dose 2. 1000 safety subset participants were telephoned at 1 month post dose 2 to collect SAEs. 500 pregnancy subset participants were contacted to collect SAEs at D7 and D21 post dose 1 and at D7, 1 month, 3 months and 6 months post dose 2, unless delivery was before these time points. The first 100 infants born to these women were given a clinical examination 3 months post delivery. Due to COVID-19 and temporary suspension of dose 2 vaccinations, at least 50 paediatric and 50 adult participants were enrolled into an immunogenicity subset to examine immune responses following a delayed second dose. Samples collected predose 2 and at 21 days post dose 2 will be tested using the Ebola viruses glycoprotein Filovirus Animal Non-Clinical Group ELISA. For qualitative research, in-depth interviews and focus group discussions were being conducted with participants or parents/care providers of paediatric participants.Approved by Comité National d'Ethique et de la Santé du Ministère de la santé de RDC, Comité d'Ethique de l'Ecole de Santé Publique de l'Université de Kinshasa, the LSHTM Ethics Committee and the MSF Ethics Review Board. Findings will be presented to stakeholders and conferences. Study data will be made available for open access.NCT04152486." @default.
- W4220789904 created "2022-04-03" @default.
- W4220789904 creator A5009631424 @default.
- W4220789904 creator A5018290525 @default.
- W4220789904 creator A5018503762 @default.
- W4220789904 creator A5020115826 @default.
- W4220789904 creator A5021754699 @default.
- W4220789904 creator A5034536995 @default.
- W4220789904 creator A5036214036 @default.
- W4220789904 creator A5039170331 @default.
- W4220789904 creator A5043150960 @default.
- W4220789904 creator A5045525792 @default.
- W4220789904 creator A5046960097 @default.
- W4220789904 creator A5052826230 @default.
- W4220789904 creator A5054399246 @default.
- W4220789904 creator A5063615518 @default.
- W4220789904 creator A5070782303 @default.
- W4220789904 creator A5075085835 @default.
- W4220789904 creator A5084456112 @default.
- W4220789904 creator A5087254032 @default.
- W4220789904 date "2022-03-01" @default.
- W4220789904 modified "2023-10-01" @default.
- W4220789904 title "Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo" @default.
- W4220789904 cites W1982754464 @default.
- W4220789904 cites W2115065945 @default.
- W4220789904 cites W2150403485 @default.
- W4220789904 cites W2342023283 @default.
- W4220789904 cites W2564361602 @default.
- W4220789904 cites W2605758023 @default.
- W4220789904 cites W2888770709 @default.
- W4220789904 cites W2896034303 @default.
- W4220789904 cites W2897618858 @default.
- W4220789904 cites W2930141921 @default.
- W4220789904 cites W2939751461 @default.
- W4220789904 cites W2955809655 @default.
- W4220789904 cites W3035074698 @default.
- W4220789904 cites W3099517149 @default.
- W4220789904 cites W3128387772 @default.
- W4220789904 cites W3199739238 @default.
- W4220789904 cites W4211119126 @default.
- W4220789904 doi "https://doi.org/10.1136/bmjopen-2021-055596" @default.
- W4220789904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35260458" @default.
- W4220789904 hasPublicationYear "2022" @default.
- W4220789904 type Work @default.
- W4220789904 citedByCount "8" @default.
- W4220789904 countsByYear W42207899042022 @default.
- W4220789904 countsByYear W42207899042023 @default.
- W4220789904 crossrefType "journal-article" @default.
- W4220789904 hasAuthorship W4220789904A5009631424 @default.
- W4220789904 hasAuthorship W4220789904A5018290525 @default.
- W4220789904 hasAuthorship W4220789904A5018503762 @default.
- W4220789904 hasAuthorship W4220789904A5020115826 @default.
- W4220789904 hasAuthorship W4220789904A5021754699 @default.
- W4220789904 hasAuthorship W4220789904A5034536995 @default.
- W4220789904 hasAuthorship W4220789904A5036214036 @default.
- W4220789904 hasAuthorship W4220789904A5039170331 @default.
- W4220789904 hasAuthorship W4220789904A5043150960 @default.
- W4220789904 hasAuthorship W4220789904A5045525792 @default.
- W4220789904 hasAuthorship W4220789904A5046960097 @default.
- W4220789904 hasAuthorship W4220789904A5052826230 @default.
- W4220789904 hasAuthorship W4220789904A5054399246 @default.
- W4220789904 hasAuthorship W4220789904A5063615518 @default.
- W4220789904 hasAuthorship W4220789904A5070782303 @default.
- W4220789904 hasAuthorship W4220789904A5075085835 @default.
- W4220789904 hasAuthorship W4220789904A5084456112 @default.
- W4220789904 hasAuthorship W4220789904A5087254032 @default.
- W4220789904 hasBestOaLocation W42207899041 @default.
- W4220789904 hasConcept C116675565 @default.
- W4220789904 hasConcept C126322002 @default.
- W4220789904 hasConcept C159047783 @default.
- W4220789904 hasConcept C162324750 @default.
- W4220789904 hasConcept C187212893 @default.
- W4220789904 hasConcept C197934379 @default.
- W4220789904 hasConcept C203014093 @default.
- W4220789904 hasConcept C22070199 @default.
- W4220789904 hasConcept C2777469322 @default.
- W4220789904 hasConcept C2778933410 @default.
- W4220789904 hasConcept C2781413609 @default.
- W4220789904 hasConcept C2908647359 @default.
- W4220789904 hasConcept C3018567284 @default.
- W4220789904 hasConcept C47768531 @default.
- W4220789904 hasConcept C535046627 @default.
- W4220789904 hasConcept C71924100 @default.
- W4220789904 hasConcept C99454951 @default.
- W4220789904 hasConceptScore W4220789904C116675565 @default.
- W4220789904 hasConceptScore W4220789904C126322002 @default.
- W4220789904 hasConceptScore W4220789904C159047783 @default.
- W4220789904 hasConceptScore W4220789904C162324750 @default.
- W4220789904 hasConceptScore W4220789904C187212893 @default.
- W4220789904 hasConceptScore W4220789904C197934379 @default.
- W4220789904 hasConceptScore W4220789904C203014093 @default.
- W4220789904 hasConceptScore W4220789904C22070199 @default.
- W4220789904 hasConceptScore W4220789904C2777469322 @default.
- W4220789904 hasConceptScore W4220789904C2778933410 @default.
- W4220789904 hasConceptScore W4220789904C2781413609 @default.
- W4220789904 hasConceptScore W4220789904C2908647359 @default.
- W4220789904 hasConceptScore W4220789904C3018567284 @default.
- W4220789904 hasConceptScore W4220789904C47768531 @default.